News

A comprehensive map of aberrant hematopoiesis in people with acute myeloid leukemia defines specific cell states and ...
Therapeutic efforts in acute myeloid leukemia (AML) face persistent challenges due to diverse and unstable cell populations ...
First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research ...
Vor Bio is the latest cell therapy company to reach the end of the road. | Vor Bio is the latest cell therapy company to ...
A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...
Investment accelerates advancement of RPT1G, a novel NAMPT inhibitor, into a Phase 1/2 trial in patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) ...
Months later, she was diagnosed with acute myeloid leukemia, a rare form of cancer. Following a successful cell transplant ... in agricultural leadership and development with economics on May ...